earnings
confidence high
sentiment negative
materiality 0.70
AdaptHealth Q1 revenue down 1.8% to $778M; net loss widens; guides FY25 lower on asset sales
AdaptHealth Corp.
2025-Q1 EPS reported
-$0.05
revenue$777,882,000
- Net revenue $777.9M (-1.8% YoY); net loss $7.2M vs $2.1M loss prior year.
- Adjusted EBITDA $127.9M (-19.3% YoY); operating cash flow improved to $95.5M.
- Sold incontinence assets; signed deal to sell infusion assets (closes Q2 2025).
- FY2025 guidance reduced: revenue $3.18B-$3.32B, Adj. EBITDA $665M-$705M.
- Diabetes segment improved for second consecutive quarter.